Advertisement

Topics

InVivo Therapeutics Corporation Company Profile

23:51 EDT 23rd June 2018 | BioPortfolio

InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of proprietary technology co-invented by Robert Langer, ScD, Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, MD, who is affiliated with Massachusetts General Hospital in Boston.


News Articles [893 Associated News Articles listed on BioPortfolio]

Active-Investors: Blog Exposure - InVivo Therapeutics Signs Share Repurchase Agreement with Lincoln Park Capital

LONDON, UK / ACCESSWIRE / January 29, 2018 / Active-Investors.com has just released a free research report on InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) ("InVivo Therapeutics"). If you want ...

InVivo Therapeutics Chooses Richard Toselli for CEO Post

Richard Toselli has been named president and CEO of InVivo Therapeutics (NASDAQ: NVIV). Toselli had been acting CEO of the Cambridge, MA, medical device developer since December. Toselli will also con...

InVivo Therapeutics announces pricing of $13.2M offering

A public stock offering has been priced by InVivo Therapeutics in hopes of raising $13.2 million in gross proceeds.  -More- 

Permanent CEO, president named by InVivo Therapeutics

Richard Toselli, who has been serving as acting CEO of InVivo Therapeutics since December, was appointed permanent CEO and pr -More- 

InVivo Therapeutics looks to raise $8M in offering

A registration has been filed by InVivo Therapeutics with the SEC for an offering of shares of common stock and Series A warr -More- 

FDA OKs second study of InVivo's neuro-spinal scaffold

The FDA has granted InVivo Therapeutics supplemental investigational device exemption approval to conduct a second pivotal st -More- 

InVivo announces reverse stock split, other company updates

A 1-for-25 reverse stock split was announced by InVivo Therapeutics, effective after market closing April 16 -- a move that w -More- 

InVivo Therapeutics, Lincoln Park reach $15M stock purchase deal

A stock purchase agreement has been reached by Lincoln Park Capital Fund to buy up to $15 million in shares from InVivo Thera -More- 

PubMed Articles [439 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Development and properties of duplex MgF2/PCL coatings on biodegradable magnesium alloy for biomedical applications.

The present work addresses the performance of polycaprolactone (PCL) coating on fluoride treated (MgF2) biodegradable ZK60 magnesium alloy (Mg) for biomedical application. MgF2 conversion layer was fi...

Clinical Trials [149 Associated Clinical Trials listed on BioPortfolio]

The Application of Invivo Microscopy Imaging in the Early Diagnosis of Cervical Cancer

This study intends to carry out a prospective, randomized controlled trial to research and development a new invivo microscopy based on the technology which is combined with high-definitio...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1415 Associated Companies listed on BioPortfolio]

InVivo Therapeutics Corporation

InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in indiv...

InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp. is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in in...

InVivo Therapeutics

InVivo Therapeutics Holdings Corp. is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in in...

InVivo Therapeutics Holding Corporation

InVivo Therapeutics Holding Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function ...

Invivo

Invivo is the pioneer in innovative RF coils to increase image quality and improve diagnostic confidence. We are the world leader in MRI monitoring, providing accurate vital signs for improved patient...

More Information about "InVivo Therapeutics Corporation" on BioPortfolio

We have published hundreds of InVivo Therapeutics Corporation news stories on BioPortfolio along with dozens of InVivo Therapeutics Corporation Clinical Trials and PubMed Articles about InVivo Therapeutics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InVivo Therapeutics Corporation Companies in our database. You can also find out about relevant InVivo Therapeutics Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...


Corporate Database Quicklinks



Searches Linking to this Company Record